Restricted Common Shares to be Traded in CREST

RNS Number : 3439X

MyCelx Technologies Corporation

28 August 2015

 

28 August 2015

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

Restricted Common Shares to be traded in CREST

MYCELX Technologies Corporation (AIM: MYX), the clean water technology company providing patented solutions for commercial industrial markets worldwide, announces that, in accordance with Regulation (EU) No. 909/2014 of the European Parliament and of the Council of 23 July 2014 on improving securities settlement in the European Union and on central depositories (the "EU Regulation") which requires all shares traded on AIM to be capable of electronic settlement, as of 1 September 2015 the existing restricted line of common shares which trades under the ticker symbol MYXR with ISIN number USU624551078 will be eligible for settlement in CREST as Depository Interests (the "Restricted DI Line").

Holders of restricted Common Shares will be able to deposit their restricted Common Shares into CREST in exchange for Depository Interests and trade such Depository Interests in uncertificated form on AIM (the "Transfer Programme"). Restricted Common Shares which participate in the Transfer Programme will continue to be subject to the restrictions on transfer. The Restricted DI Line will continue to use the ticker symbol MYXR and ISIN number USU624551078.

Holders of restricted Common Shares who do not participate in the Transfer Programme will continue to hold their Common Shares in certificated form, which will retain their legend and the restrictions on transfer. Consequently, trading in certificated restricted Common Shares may continue to take place. However, such holders of certificated restricted Common Shares should note that certificated stock is not capable of electronic settlement in accordance with the EU Regulation and will need to be dematerialised prior to electronic settlement. No Common Shares will be deposited into CREST without the positive action of the relevant shareholder.

In general, under US securities law, Common Shares that have been in issue for more than one year and are not held by an 'affiliate' of the Company qualify for characterisation as unrestricted Common Shares ("Unrestricted Common Shares"). An affiliate for this purpose is a person that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, the Company or a director or officer of the Company. All Unrestricted Common Shares are eligible for migration to, and trading on, the Company's unrestricted MYX line with the ISIN number US62847T2024.

There has been no change in the Company's issued share capital. The Company will continue to have a total of 18,770,117 Common Shares admitted to trading on AIM (excluding those Common Shares admitted and not allotted under the blocklisting announced on 25 February 2011). The Company holds no Common Shares in treasury.

The Company will be writing to shareholders affected shortly to inform them of the process of moving their shares to the Restricted DI Line. 

For further information please contact:

MYCELX Technologies Corporation Connie Mixon, CEO Mark Clark, CFO	Tel: [phone]
RFC Ambrian Limited Corporate Finance Samantha Harrison Alexander Millar Corporate Broking Jonathan Williams Kim Eckhof	Tel: [phone]
Numis Securities Limited   Corporate Broking James Black Ben Stoop	Tel: [phone]
Bell Pottinger   Nick Lambert Henry Lerwill	Tel: [phone]

 

END

 

 

MSCLLFISTRIDFIE